870
Participants
Start Date
September 30, 2012
Primary Completion Date
March 31, 2014
Study Completion Date
April 30, 2014
LDV/SOF
LDV/SOF 90/400 mg FDC tablet administered orally once daily
RBV
RBV tablets administered orally in a divided daily dose according to package insert weight-based dosing recommendations (\< 75 kg = 1000 mg and ≥ 75 kg = 1200 mg)
Birmingham
La Jolla
Long Beach
Los Angeles
Palo Alto
Sacramento
San Diego
Aurora
Englewood
Washington D.C.
Gainesville
Miami
Orlando
Tampa
Wellington
Atlanta
Decatur
Marietta
Chicago
Indianapolis
Baltimore
Lutherville
Boston
Detroit
Rochester
Saint Paul
Kansas City
St Louis
Hillsborough
Albuquerque
Santa Fe
Manhasset
New York
The Bronx
Asheville
Chapel Hill
Durham
Fayetteville
Statesville
Winston-Salem
Cincinnati
Philadelphia
Germantown
Nashville
Arlington
Dallas
Houston
San Antonio
Fairfax
Falls Church
Norfolk
Richmond
Seattle
CHRU Lille
Clichy
Créteil
La Tronche
Lyon
Marseille
Nice
Paris
Berlin
Cologne
Düsseldorf
Essen
Frankfurt
Freiburg im Breisgau
Hamburg
Hanover
Mainz
Bologna
Brescia
Milan
Padua
Palermo
Roma
San Giovanni Rotondo
Torino
San Juan
Barcelona
Madrid
Málaga
Santander
Seville
Birmingham
London
Manchester
Plymouth
Lead Sponsor
Gilead Sciences
INDUSTRY